Key result
Minimally invasive mitral valve surgery was associated with an overall in-hospital mortality of 1.7%, with observed mortality significantly lower than expected by EuroSCORE II across all risk categories.
Why the study?
With the rise of catheter-based mitral procedures, evaluating risk-specific clinical outcomes after contemporary mitral valve surgery and assessing EuroSCORE II for risk prediction was needed.
Observational (n=6,541)
Yes
Minimally invasive mitral valve surgery is associated with excellent in-hospital outcomes across low, intermediate, and high-risk patients, with EuroSCORE II consistently overestimating mortality.
Answers are grounded in this paper and cite their sources.
EuroSCORE II overestimates mortality after mini-mitral surgery across risk strata; leaves open its role in extreme-risk selection pending prospective data.
OBJECTIVES: With the popularization of catheter-based mitral valve procedures, evaluating risk-specific differentiated clinical outcomes after contemporary mitral valve surgery is crucial. In this study, we assessed the operative results of minimally invasive mitral valve operations across different patient risk profiles and evaluated the value of EuroSCORE (ES) II predicted risk of mortality model for risk prediction, in the large cohort of Mini-Mitral International Registry (MMIR). METHODS: The MMIR database was used to analyse mini-mitral operations between 2015 and 2021. Patients were categorized as low (<4%), intermediate (4% to <8%), high (8% to <12%) and extreme risk (≥12%) according to ES II. The observed-to-expected mortality ratio was calculated for each risk group. RESULTS: A total of 6541 patients were included in the analysis. Of those, 5546 (84.8%) were classified as low risk, 615 (9.4%) as intermediate risk, 191 (2.9%) as high risk and 189 (2.9%) as extreme risk. Overall operative mortality and stroke rates were 1.7% and 1.4%, respectively, and were significantly associated with patient's risk. The observed mortality was significantly lower than expected-according to the ES II-in all risk categories (observed-to-expected ratio < 1). CONCLUSIONS: The present study provides an international contemporary benchmark for operative outcomes after minimally invasive mitral surgery. Operative results were excellent in low-, intermediate- and high-risk patients, but were less satisfactory in extreme risk. The ES II model overestimated the in-hospital mortality. We believe that findings from the MMIR may assist surgeons and cardiologists in clinical decision-making and treatment allocation for patients with mitral valve disease.
No takes yet. Share an insight, caveat, or question.
Berretta et al. (2023) conducted an observational in Mitral valve disease (n=6,541). Minimally invasive mitral valve surgery vs. Expected mortality (EuroSCORE II) was evaluated on All-cause operative mortality. Minimally invasive mitral valve surgery was associated with an overall in-hospital mortality of 1.7%, with observed mortality significantly lower than expected by EuroSCORE II across all risk categories.
Synapse has enriched 10 related papers. Consider them for comparative context: